Tuberculosis is Rare in Developed Countries
Tubrculosis (abbreviated TB for Tubercle Bacillus) is associated with various mycobacterium classes such as Mycobacterium tuberculosis and Mycobacterium bovis. In the USA TB is in present only in socially marginal groups, largely out of sight. Tuberculosis is a chronic bacterial infection listed as a “rare disease” by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Tuberculosis, or a subtype of Tuberculosis, affects less than 200,000 people in the US population.
Tuberculosis Vaccination is Not the Answer
Like many other communicable diseases, thirty percent of the human population harbors the microorganism yet most are asymptomatic. The incidence of pathogenic tuberculosis has much more to do with public hygiene and quality of life conditions (i.e. healthy immune systems) than the germ itself.
Although, worldwide, tuberculosis is common and causes more deaths worldwide than any other infectious disease, it is only found in impoverished areas with poor nutrition and sanitation. Instead of spending millions of dollars on research, production, testing, licensing, marketing, and administration of questionable vaccines, wouldn’t it be wiser to spend our resources improving the living conditions and infrastructure of the underprivileged? Addressing the cause (poor nutrition, living conditions, etc) makes more sense that treating the effect.